在骨髓瘤向治疗中MET信号通路的作用和研究进展
Qilong Su1, Jingyu Hou1, Xinhui Du1
1The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Oncology reviews
|July 2, 2025
概括
甲状腺转移受体氨酸激酶信号驱动骨髓瘤 (OS) 的进展. 包括组合治疗在内的MET向疗法,有望改善OS患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 作为受体氨酸激酶的MET在骨髓瘤 (OS) 发病和进展中至关重要.
- 持续的MET通路激活通过下游信号 (RAS-ERK,PI3K-AKT,STAT3) 驱动OS细胞的增殖,入侵,分化和耐药性.
研究的目的:
- 审查骨髓瘤中MET信号传递的机制.
- 总结针对MET的治疗方法和OS治疗的组合策略的进展.
主要方法:
- 文献综述专注于骨髓瘤中MET信号通路的研究.
- 对当前和新兴的MET向治疗方法的分析.
- 评估涉及MET抑制剂的组合疗法策略.
主要成果:
- MET信号是骨髓瘤发展和进展的关键驱动力.
- 小分子抑制剂和针对MET的抗体正在为OS疗法推进.
- 组合疗法 (MET抑制剂与化疗,免疫疗法或其他向药物) 显示出克服耐药性和提高疗效的潜力.
结论:
- 在骨髓瘤中,MET是重要的治疗点.
- 针对MET,特别是通过组合疗法,提供了一个有前途的策略,以改善骨髓瘤患者的治疗结果.
- 对MET向疗法及其组合进行进一步的研究是有必要的,这将为OS治疗提供新的视角.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K


